Harmony Biosciences Holdings, Inc.HRMYNASDAQ

Revenue (LTM)

$868M

+21.5% YoY

Net Income (LTM)

$159M

+9.1% YoY

Free Cash Flow

$348M

Revenue CAGR (5Y)

+29.9%

Marginsdeclining

FCF$0.3B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	305	438↑43.4%	582↑32.9%	715↑22.8%	868↑21.5%
Gross Profit	250	354↑41.8%	461↑30.0%	558↑21.1%	670↑20.1%
Operating Income	88	120↑37.3%	192↑59.8%	191↓0.6%	208↑9.2%
Net Income	35	181↑424.5%	129↓29.0%	145↑12.9%	159↑9.1%
EBITDA	80	147↑82.5%	222↑50.8%	233↑5.4%	255↑9.3%
EPS Diluted	0.58	2.97↑412.1%	2.13↓28.3%	2.51↑17.8%	2.71↑8.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	234	244↑4.0%	312↑27.8%	453↑45.4%	753↑66.1%
Total Current Assets	284	400↑40.7%	451↑12.7%	579↑28.4%	907↑56.6%
Total Assets	433	674↑55.5%	811↑20.4%	999↑23.1%	1,272↑27.3%
Total Current Liabilities	54	79↑46.7%	164↑107.6%	175↑6.9%	252↑44.0%
Total Liabilities	247	271↑9.8%	344↑27.1%	340↓1.3%	401↑18.0%
Total Equity	187	403↑116.0%	467↑15.9%	659↑41.1%	870↑32.0%
Total Debt	196	192↓2.1%	194↑1.0%	181↓6.3%	240↑32.1%
Net Debt	-39	-52↓35.2%	-118↓126.5%	-272↓130.0%	-513↓88.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	99	144↑46.6%	219↑51.9%	220↑0.2%	348↑58.4%
Capital Expenditure	-0	-0↑42.3%	-0↓81.4%	-1↓269.6%	-0↑73.1%
Free Cash Flow	98	144↑46.9%	219↑51.8%	219↓0.2%	348↑59.1%
Stock-Based Comp	16	27↑67.1%	32↑17.8%	43↑34.4%	45↑5.4%
Net Change in Cash	6	9↑66.9%	67↑611.3%	141↑109.7%	300↑111.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance